title: In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
authors.forename: M
authors.initials: M
authors.lastname: Smith
authors.forename: M A
authors.initials: MA
authors.lastname: de Souza
authors.forename: S
authors.initials: S
authors.lastname: Pugliese
authors.forename: J de J
authors.initials: Jde J
authors.lastname: Mari
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001712:Biperiden / Q000009:adverse effects*; D016022:Case-Control Studies; D002478:Cells, Cultured; D002746:Chlorpromazine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009152:Mutagenicity Tests; D009153:Mutagens; D010640:Phenothiazines / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D009153:Mutagens; D010640:Phenothiazines; D001712:Biperiden; D006220:Haloperidol; C084783:pipothiazine; D002746:Chlorpromazine